DCN and inflammatory breast carcinoma: The lack of decorin in various mouse models of mesenchymal and epithelial neoplasms is permissive for tumorigenesis [61,62,63]; conversely, decorin can suppress tumorigenesis, invasion, and metastasis of inflammatory breast cancer [64].